The latest proposal for a patch that helps treat children suffering from attention deficit hyperactivity disorder is being interrupted by concerns of The Food and Drug Administration.

According to the FDA, there's a problem with the ADHD patch. An FDA scientist has given it a negative review, saying it can't be marketed safely.

The FDA reviewer reports the patch has troubling side effects of decreased appetite, headache, insomnia, nausea and tics.

A review by an independent panel of experts is still pending, however. The panel also makes a recommendation to the FDA, which has the final say on whether the patch will be made available to the public.

The patch was developed by Noven Pharmaceuticals of Miami and Shire Pharmaceuticals Group in the United Kingdom. It uses methylphenidate, the same drug that is in Ritalin.